Lüneberg et al., 1998 - Google Patents
Phase-variable expression of lipopolysaccharide contributes to the virulence of Legionella pneumophilaLüneberg et al., 1998
View PDF- Document ID
- 4951142049333819113
- Author
- Lüneberg E
- Zähringer U
- Knirel Y
- Steinmann D
- Hartmann M
- Steinmetz I
- Rohde M
- Köhl J
- Frosch M
- Publication year
- Publication venue
- The Journal of experimental medicine
External Links
Snippet
With the aid of monoclonal antibody (mAb) 2625, raised against the lipopolysaccharide (LPS) of Legionella pneumophila serogroup 1, subgroup OLDA, we isolated mutant 811 from the virulent wild-type strain RC1. This mutant was not reactive with mAb 2625 and …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lüneberg et al. | Phase-variable expression of lipopolysaccharide contributes to the virulence of Legionella pneumophila | |
| Atkins et al. | Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis | |
| Pier | Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity | |
| Albus et al. | Virulence of Staphylococcus aureus mutants altered in type 5 capsule production | |
| Zwahlen et al. | Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats | |
| Moran et al. | Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity | |
| Gulati et al. | Targeting lipooligosaccharide (LOS) for a gonococcal vaccine | |
| Pier | Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen | |
| Serino et al. | Genetic and functional analysis of the phosphorylcholine moiety of commensal Neisseria lipopolysaccharide | |
| Chakraborti et al. | Phase-variable heptose I glycan extensions modulate efficacy of 2C7 vaccine antibody directed against Neisseria gonorrhoeae lipooligosaccharide | |
| Patrick et al. | Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway | |
| Peterson et al. | Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae | |
| Porat et al. | A lipooligosaccharide-binding site on HepG2 cells similar to the gonococcal opacity-associated surface protein Opa | |
| Chatterjee et al. | Lipopolysaccharides of Vibrio cholerae: III. Biological functions | |
| Weynants et al. | Genetically modified L3, 7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response | |
| Kreger et al. | Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera | |
| NL8700286A (en) | CROSS-PROTECTIVE HUMANE MONOCLONAL ANTI-BODY PREPARATIONS. | |
| Robins-Browne et al. | Pathogenicity of Yersinia kristensenii for mice | |
| Ellis et al. | The Neisseria gonorrhoeae lpxLII gene encodes for a late‐functioning lauroyl acyl transferase, and a null mutation within the gene has a significant effect on the induction of acute inflammatory responses | |
| Ali et al. | Detection and characterization of bacterial polysaccharides in drug-resistant enterococci | |
| Sengupta et al. | Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge | |
| Woods | Pathogenesis of acute and chronic Pseudomonas aeruginosa infections | |
| Wu et al. | The GE296_RS03820 and GE296_RS03830 genes are involved in capsular polysaccharide biosynthesis in Riemerella anatipestifer | |
| Sequeira | Determinants of plant response to bacterial infection | |
| Simberkoff et al. | Specific and nonspecific immunity to Serratia marcescens infection |